אבוסינאגיס 50 מ"ג

País: Israel

Língua: hebraico

Origem: Ministry of Health

Ingredientes ativos:

PALIVIZUMAB 50 MG

Disponível em:

ABBVIE BIOPHARMACEUTICALS LTD, ISRAEL

Código ATC:

J06BB16

Forma farmacêutica:

POWDER FOR SOLUTION FOR INJECTION

Via de administração:

I.M

Fabricado por:

ABBVIE S.R.L., ITALY

Grupo terapêutico:

PALIVIZUMAB

Indicações terapêuticas:

Is indicated for the prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (RSV). Safety and efficacy were established in infants with bronchopulmonary dysplasia (BPD) and in infants with a history of prematurity (35 weeks gestational age) and in children less then 2 years of age,with haemodynamically significant congenital heart disease.

Data de autorização:

2010-07-01